Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04134780 · ClinicalTrials.gov registry record
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
A clinical trial of Breast Cancer, sponsored by Sunnybrook Health Sciences Centre.
- Recruiting
- Registry status
- 150
- Enrollment target
- 3
- Study locations
NCT04134780: Recruiting study of Breast Cancer, sponsored by Sunnybrook Health Sciences Centre.
NCT04134780 is a study of Breast Cancer that is actively recruiting participants, run by Sunnybrook Health Sciences Centre. The registered enrollment target is 150 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04134780, a study of Breast Cancer, is actively recruiting participants, sponsored by Sunnybrook Health Sciences Centre.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
This work explores the possibility of using ultrasound imaging and spectroscopy as a way of monitoring cell death, hence, tumour response to treatment. The hypothesis here is that it can be used as a way of monitoring early response to cancer treatment and predicting which patients continue on in their therapy to have a complete pathological response as a primary endpoint and tumour size decrease as a secondary endpoint. If this work is successful it could be used in the future early on in a cancer patient's treatment to predict whether or not a course of chemotherapy or radiotherapy is going to be successful. For example, in patients in which the analysis indicates a poor response the chemotherapy regimen could be changed to a more efficacious one or for those receiving radiotherapy predicted to have a poor response a radiosensitizing agent could be used to improve outcome.
Conditions Studied
Study Locations (3)
Ontario
- Sunnybrook Health Sciences Centre - Toronto
- Princess Margaret Cancer Centre - Toronto
Texas
- MD Anderson - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-08 |
| Est. Completion | 2029-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04134780
The ClinicalTrials.gov registry entry for NCT04134780 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Sunnybrook Health Sciences Centre, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT04134780 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Ontario, Texas.
Frequently Asked Questions
What is clinical trial NCT04134780 about?
NCT04134780 is a clinical study titled "Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response". This work explores the possibility of using ultrasound imaging and spectroscopy as a way of monitoring cell death, hence, tumour response to treatment. The hypothesis here is that it can be used as a way of monitoring early response to cancer treatment and predicting which patients continue on in th...
What is the current status of trial NCT04134780?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2014-08. Estimated completion is 2029-10.
What conditions does trial NCT04134780 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT04134780?
This trial is sponsored by Sunnybrook Health Sciences Centre, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04134780 being conducted?
This trial has 3 study locations across Texas, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.